Aggressive Stem Cells Might Improve Transplant Outcome

Main Category: Stem Cell Research
Also Included In: Transplants / Organ Donations
Article Date: 08 Dec 2006 - 0:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:not yet rated

Healthcare Prof:3 stars

3 (1 votes)


Investigators at St. Jude Children's Research Hospital have demonstrated in mice a way that might reduce the time it takes for a bone marrow cell transplant to rebuild a child's immune system, and so reduce the risk of potentially fatal virus infections that can occur during this time.

A report on this work appears in the current online issue of the journal Stem Cell.

The St. Jude team showed that the current way of harvesting specific stem cells from donated bone marrow to capture many of the stem cells called CD34+ cells fails to capture many of those that might be more vigorous in reproducing and rebuilding the immune system.

Specifically, they demonstrated that the current method of using a so- called class II antibody captures most of the less aggressive CD34+ cells. But using both a class II and class III antibody against CD34+ cells captures many of the more vigorous cells according to Raymond Barfield, M.D., Ph.D., assistant member of the St. Jude Bone Marrow Transplantation division and senior author of the report.

Other authors of this study include Mario Otto (now at Akron Children's Hospital, Ohio); Xiaohua Chen, William J. Martin, Wing Leung, James Knowles, Marti Holladay and Jim Houston (all of St. Jude); and Rupert Handgretinger (University of Tubingen, Germany). This work was supported in part by a Cancer Center Support grant, ALSAC and the Assisi Foundation of Memphis.

St. Jude Children's Research Hospital

St. Jude Children's Research Hospital is internationally recognized for its pioneering work in finding cures and saving children with cancer and other catastrophic diseases. Founded by late entertainer Danny Thomas and based in Memphis, Tenn., St. Jude freely shares its discoveries with scientific and medical communities around the world. No family ever pays for treatments not covered by insurance, and families without insurance are never asked to pay. St. Jude is financially supported by ALSAC, its fund-raising organization. For more information, please visit http://www.stjude.org/.

St. Jude Children's Research Hospital
http://www.stjude.org/

Article adapted by Medical News Today from original press release.
Visit our stem cell research section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Christopher Backing. "Aggressive Stem Cells Might Improve Transplant Outcome." Medical News Today. MediLexicon, Intl., 8 Dec. 2006. Web.
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/58463.php>

APA
Christopher Backing. (2006, December 8). "Aggressive Stem Cells Might Improve Transplant Outcome." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/58463.php.

Please note: If no author information is provided, the source is cited instead.


Stem Cell Research

What are Stem Cells?

Stem cells are a class of undifferentiated cells that are able to differentiate into specialized cell types. Commonly, stem cells come from two main sources: embryonic stem cells and adult stem cells Read more...

Most Popular Articles



Follow Our Stem Cell Research News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Stem Cell Research Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »